FisherVista

Silvercorp Metals Inc. expects a temporary production slowdown at its Ying and GC mining operations in China as it implements new nationwide mine safety requirements following a fatal coal mine accident in May.

TechForce Robotics has completed the first deployment of its LIM-E autonomous laboratory support robot at Oncotelic Therapeutics, marking its entry into pharmaceutical automation and potentially transforming routine lab logistics.

New consumer research from A2Z Cust2Mate Solutions Corp. shows a significant gap between what shoppers want—fast, hassle-free experiences with clear pricing—and what they believe supermarkets deliver, with tangible business impacts including abandoned purchases and lost sales.

MAX Power Mining announced that an independent petrophysical evaluation by GLJ Ltd. confirmed multiple prospective natural hydrogen and helium zones at its Bracken exploration well in Saskatchewan, supporting plans for testing and commercial validation.

HeartBeam Inc. has completed patient enrollment in its ALIGN-ACS pilot study evaluating its 3D ECG technology for heart attack detection, with results expected to support FDA discussions and potential acceleration of regulatory approval.

Lahontan Gold Corp. provides an update on its Santa Fe Mine Project in Nevada, reporting progress on drilling, permitting, and key milestones that keep the project on track for a 2027 construction start, with potential implications for gold production in the region.

Silvercorp Metals Inc. has filed its fiscal 2026 annual report and an updated NI 43-101 technical report for its Curipamba-El Domo polymetallic project in Ecuador, providing investors with critical financial and project data.

Silo Pharma announced a robustness study for its intranasal PTSD treatment candidate SPC-15, supporting regulatory guidance and Phase 1 trial design.

Onco-Innovations Ltd. has achieved kilogram-scale production of its lead drug candidate ONC010, a PNKP inhibitor that disrupts cancer cells' DNA repair, and signed a Letter of Intent with Nanosoft Polymers to optimize drug delivery, marking progress in a new class of DDR therapies for hard-to-treat cancers.

Globavend Holdings launched its first AI-produced micro drama, "Buried Innocent," using its proprietary Imaginary platform, signaling a strategic expansion into the global micro-drama market with a vertically integrated AI-powered entertainment ecosystem.

LataMed AI Corp. announced a commercial alliance with Venezuelan insurer Vértice Seguros to integrate insurance services into its digital healthcare platform, expanding access to healthcare and insurance for patients in Venezuela.

This article explains the IPO process, the risks and rewards for retail investors, and how platforms like SoFi are democratizing access to IPO shares.

InPlay Global and tZERO are collaborating to develop Sports Performance Securities, equity instruments tied to team performance, aiming to establish a new investable asset class for sports fans and investors.

Vision Marine Technologies has developed a comprehensive electric marine propulsion platform, integrating manufacturing, distribution, and commercial execution to scale electric recreational boating.

BioElectronics Corporation announced a small profit for 2025, sales growth, and progress with Electrome Corporation, positioning itself in the non-opioid pain management market.

One World Products and Los Gatos Tomato Products announce plans to jointly develop advanced engineered materials from agricultural feedstocks, expanding the AgriBlend platform. The partnership aims to create high-performance materials for multiple industries, leveraging tomato pomace and almond byproducts, with broader impl...

A real estate agent reveals that Seaside Heights and Belmar have transformed with new luxury construction and higher prices, challenging outdated perceptions from the MTV show and urging buyers to reconsider these markets.

Lifespan Edge, co-founded by futurist John Mauldin and Dr. Michael Roizen, opens two new concierge longevity clinics in West Palm Beach and Columbia, with a third planned for Scottsdale, aiming to advance personalized preventive care and research into Therapeutic Plasma Exchange.

Mitch Gould, founder of Nutritional Products International, shares insights on the American Dream and entrepreneurship, highlighting lessons from his memoir and his company's role in helping international brands enter the U.S. market.